Search Results

Not a healthcare professional? Visit our Public site

For UK healthcare professionals

Not a healthcare professional? Visit our Public site

This site contains promotional material

Communication preferences

User logged in

Report adverse event

Overlay Text

For UK Healthcare Professionals

This site contains promotional material

Visit our Public site

Account activated – Pending validation

Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website.

Registration completed – pending validation

Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result of the validation process. Please note this could take up to 10 days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website.

Account activated – Pending validation

Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website.

Event Account activated - pending validation.

In the meantime, you can enjoy access to all the latest news, events and resources on our website.

already registered

X »

has been added to your basket

View basket

Popup

ASYEVE0001=Event Registration-Portal
ASYEVE0002=Watched General Video
ASYEVE0003=Watched Virtual Rep Video
ASYEVE0004=Watched Patient Video
ASYEVE0005=Watched Expert Video
ASYEVE0006=Watched Webcast
ASYEVE0007=Downloaded Content-Portal
ASYEVE0008=Clicked to App Store
ASYEVE0009=Watched Learning Module Video
ASYEVE0010=eMail Sent
ASYEVE0011=eMail Read
ASYEVE0012=eMail Clicked
ASYEVE0013=Shared a Link
ASYEVE0014=Rep Request
ASYEVE0015=Joined health.gsk
ASYEVE0016=email Not Sent
ASYEVE0017=Email Not Sent
ASYEVE0018=Email Not Sent
ASYEVE0037=IJSFAID is not available
ASYEVE0038=EMAIL ID and IJSFAID is not available
ASYEVE0039=The user is opted out
ASYEVE0040=Scope IDs are different

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Unit for Hours:H

Unit for Minutes: M

Loading text: $loading

Filter redirection page URL: /en-gb/events/

Filter Tags:Product|Therapy

Filter Tags values when filtered by all Tags:All Medical indications|All Products|All Therapy Area

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successfull

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successfull

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:Not Provided

Month Names:January,February,March,April,May,June,July,August,September,October,November,December

Month Names Short:Jan,Feb,Mar,Apr,May,Jun,Jul,Aug,Sep,Oct,Nov,Dec

Day Names:Sunday,Monday,Tuesday,Wednesday,Thursday,Friday,Saturday

Day Names Short:Sun,Mon,Tue,Wed,Thu,Fri,Sat

Day Names Min:Sun,Mon,Tue,Wed,Thu,Fri,Sat

Date Format:mm/dd/yy

Events Filter Date Placeholder:dd-mm-yyyy

Title

Video player requires JavaScript enabled.

Description

212 result(s)

GSKpro for UK healthcare professionals

A portal for UK healthcare professionals containing GSK product information, patient resources, exclusive webinars and more

oneClickSuccessPage

oneClickErrorPage

Consent Management

Registration Email Validation

Ordering and delivery

Find out how to set up an account and start ordering GSK vaccines.

Login

Contact Us Confirmation

Basket

Tackle Meningitis

covid-19

Checkout

FendrixTile1

LamictalTile2

MenitorixTile2

EumovateView PIL

CutivateTile2

Benlysta View Spc

GSK vaccines support

Ventolin View SPC

ReQuip Tile1

vaccines.co.uk

Naramig Tile1

Flixonase View SPC

FluarixTile1

Bexseo_pil

Adartrel - View SPC

Varilrix View SPC

View pil zovirax

ReQuip Tile2

Duac PIL

ImigranTile1

Ventolin View PIL

Wellvone view spc

Duac SPC

Priorix Tile2

Requip Xl Tile2

Avodart View Pil

Relenza Tile2

Valtrex View PIL

Boostrix view pil

LamictalTile1

Combodart view spc

Varilrix View PIL

View pil zyban

MenitorixTile1

Betnovate View SPC

Tacklemeningitis

Malarone ViewSPC

Benlysta EPAR

Fendrix EPAR

Nimbex/NimbexForte Tile2

Avodart View Spc

Wellvone-view-pil

AnectineTile2

DermovateView PIL

Cutivate Tile1

View SPC zovirax

Adartrel View PIL

BetnovateView PIL

Malarone ViewPIL

Relenza Tile1

Bactroban View SPC

DaraprimTile2

ViiV Exchange website

view spc zyban

View SPC Mivacron

View SPC

View Pil Mivacron

Requip Xl Tile1

Benlysta View pil

Test

Flixotide View SPC

FendrexTile2

Flixonase View PIL

FlolanTile1

Serevent ViewPIL

Dermovate View SPC

Combodart view pil

Bactroban View PIL

FluarixTile2

Infanrix-IPV+Hib tile 1

Priorix Tile1

Seroxat Tile1

Serevent ViewSPC

Nimbex/NimbexForte Tile1

FlixotideView PIL

Beconase View PIL

Trimovate View PIL

View pil

Eumovate View SPC

ImigranTile2

IntegrilinTile2

Valtrex View SPC

Infanrix-IPV+Hib tile 2

Naramig Tile2

Seroxat Tile2

Beconase View SPC

Vaccines

DaraprimTile1

IntegrilinTile1

Boostrix view spc

Registration Token

COPD

ellipta-overview

Ellipta

Update Password Confirmation

Update Password

Send Confirmation Token

Login

xevudy

Seretide

DECTOVA▼

zanamivir IV Influenza

Report a possible side effect | GSKpro

Information for UK healthcare professionals on how to report an adverse event related to a GSK product

Request a contact

patient resource

Reset Password

Unsubscribe

Unsubscribe-lite

Access GSK Page

Arexvy

AREXVY▼

Respiratory Syncytial Virus Vaccine, Adjuvanted Vaccines

This summer, how can GSK help you deliver the non-seasonal shingles National Immunisation Programme?

Respiratory

Overview of COPD and severe asthma.

Shingrix MT

Immunocompromised Clinical Data | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Shingrix

GSKpro Efficacy | SHINGRIX

SHINGRIX information for UK healthcare professionals only

GSKpro Safety | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Immunocompromised patients

Driving uptake of the Shingles Immunisation Programme: Discussing best practice

Shingles Awareness Week 2024: Accelerating immunisation in your most vulnerable patients

Severe Asthma

Ellipta critical error studies in COPD

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients

XEVUDY ▼ (sotrovimab)

XEVUDY▼ (sotrovimab) label information for patients and healthcare professionals in Great Britain, including summary of product characteristics and patient information leaflet.

Login

Registration

login-proxy

ZEJULA

niraparib Oncology

OMJJARA▼

momelotinib Oncology

Therapy areas | GSKpro UK

Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.

Nucala (mepolizumab) Safety

Nucala (mepolizumab) UK | Safety | This page contains safety and promotional information about Nucala (mepolizumab). For UK Healthcare Professionals only.

SEA Efficacy

CRSwNP Efficacy

identifying-patients-redirect

Efficacy

Efficacy | Nucala (mepolizumab)

Key Nucala (mepolizumab) efficacy data | This website contains promotional information and is for UK healthcare professionals only.

Burden of disease landing page

Page explaining burden of disease. | This website contains promotional information about NUCALA (mepolizumab) and is for UK healthcare professionals only.

Nucala (mepolizumab) Home UK

Nucala (mepolizumab) UK | Home | This page contains promotional information about Nucala (mepolizumab). For UK Healthcare Professionals only.

Nucala

COPD guidelines

Token Sent

BLENREP▼

belantamab mafodotin

COPD Guidelines

Information about COPD Guidelines and CV Risk to support UK healthcare professionals

Contact | GSKpro UK

GSK UK contact page for healthcare professionals.

IMT Guidelines

Information about COPD Guidelines to support UK healthcare professionals

Relvar (fluticasone furoate/vilanterol): Supporting your eligible patients with asthma

Relvar Ellipta

Discontinued products | GSK Pro

Discontinued products

Device

AREXVY

GSKpro Impact of Shingles | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Vaccines

GSK UK information about our vaccines

Resources | GSKpro

For UK HCPs. Support your patients and practice with these healthcare resources, ranging from training devices to patient support information.

trelegy

Anoro

Relvar Ellipta (fluticasone furoate/vilanterol)

Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder) information for Healthcare Professionals registered in Ireland.

Jemperli

JEMPERLI ▼

dostarlimab Oncology

Webinars & events | GSKpro

A collection of promotional events and webinars featuring experts for UK healthcare professionals

GSK Trelegy – Homepage

Trelegy Ellipta Homepage. GSKPro for UK healthcare professionals.

Coming soon | GSKpro

This page is under construction. If you require assistance, please connect with our Customer Support team via live chat or request to be contacted by a suitable GSK contact.

ICS/LABA

Information about ICS/LABA in COPD to support UK healthcare professionals

GSKpro Home | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Webinars & events | GSKpro

A collection of promotional events and webinars featuring experts for UK healthcare professionals

GSKpro Implementation | SHINGRIX (Herpes Zoster vaccine recombinant, adjuvanted)

SHINGRIX information for UK healthcare professionals only

Programme Implementation

GSKpro Patient Referrals | SHINGRIX

Shingles National Immunisation Programme information for UK healthcare professionals only

GSK Trelegy - Comparative Effectiveness Study

Trelegy Ellipta Comparative Effectiveness Study. GSKPro for UK healthcare professionals.

Nucala (mepolizumab) Expert Perspectives UK

Nucala (mepolizumab) | Expert Perspectives I This page contains promotional information about Nucala (mepolizumab). For UK Healthcare professionals only

Immunocompromised | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Supply

Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability

Second Dose

Understanding the importance of the second dose of SHINGRIX (herpes zoster vaccine recombinant, adjuvanted) | This website contains promotional information about SHINGRIX and is for UK healthcare professionals only

GSKpro SHINGRIX overview | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Multiple myeloma second-line treatment outcomes | GSK UK

Explore the challenges of treating relapsed and refractory multiple myeloma, and the unmet need for effective second-line treatment options. For UK HCPs only.

BLENREP▼ (belantamab mafodotin) | GSK UK

BLENREP (belantamab mafodotin) in two different treatment combinations is approved for use in patients with multiple myeloma at first relapse. For UK HCPs only.

About BLENREP

BLENREP▼ + Vd: Clinical trial efficacy & safety data | GSK UK

Review the BLENREP (belantamab mafodotin) + Vd efficacy and safety data from the Phase III DREAMM-7 trial. For UK HCPs only.

BLENREP▼ (belantamab mafodotin) MoA | GSK UK

BLENREP▼ (belantamab mafodotin) is a BCMA-targeted therapy for multiple myeloma that combines targeted mAbs with cytotoxic drugs. For UK HCPs only.

DREAMM-7 BLENREP▼ (belantamab mafodotin) Trial | GSK UK

Overview of DREAMM-7 phase 3 trial investigating triplet therapy (BLENREP▼ +Vd) vs a daratumumab triplet (DVd) for multiple myeloma. For UK HCPs only.

BLENREP▼ (belantamab mafodotin) dosing can be delayed, reduced, or discontinued as part of a strategy to manage side effects

Managing eye-related and non-eye-related side effects of BLENREP (belantamab mafodotin). For UK HCPs only.

Using BLENREP

BLENREP▼ Dosing and administration | GSK UK

Explore BLENREP▼ (belantamab mafodotin) dosing and administration, including info on schedules, reductions, delays and infusion time. For UK HCPs only

BLENREP▼ (belantamab mafodotin) resources

Access resource materials to support BLENREP (belantamab mafodotin) implementation in practice and to help your patients receiving BLENREP. For UK HCPs only.

Supporting patients on BLENREP▼

Guidance for UK healthcare professionals to support patients on BLENREP (belantamab mafodotin). For UK HCPs only.

Resources and more

BLENREP + Pd: Clinical trial efficacy & safety data | GSK UK

Review the BLENREP (belantamab mafodotin) + Pd efficacy and safety data from the Phase III DREAMM-8 trial. For UK HCPs only.

Blenrep

DREAMM-8 BLENREP▼ (belantamab mafodotin) Trial | GSK UK

Overview of DREAMM-8 phase 3 trial investigating BLENREP▼triplet therapy (BPd) vs a pomalidomide triplet (PVd) for multiple myeloma. For UK HCPs only.

BLENREP▼ (belantamab mafodotin) news and updates | GSK UK

Stay informed with the latest news and updates on BLENREP (belantamab mafodotin). For UK HCPs only.

The multiple myeloma experts | GSK UK

Learn more about the BLENREP▼ (belantamab mafodotin) experts at GSK. For UK HCPs only.

Products | GSKpro

GSK product information for UK healthcare professionals

No results. Why not try:

Checking the spelling of the search term
Trying a different search term
Resetting or revising the filter settings (if you used filters to do this search)

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.